杂志简称：dev med child neurol
中文译名：《发育医学与儿童神经病学》
收录属性：scie（2024版）, 英文期刊,
自引率：9.60%
投稿方向：医学、pediatrics 儿科、clinical neurology 临床神经病学
SCI/E期刊基本信息
出版周期：月刊 地区：英国
中科院分区：2区
是否TOP：TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN0012-1622；EISSN1469-8749
杂志语言：英语
出版国家：英国
杂志官网 联系方式
出版地址：WILEY-BLACKWELL PUBLISHING,INC,COMMERCE PLACE,350 MAIN ST,MALDEN,USA,MA,02148
杂志邮箱：
投稿网址：http://mc.manuscriptcentral.com/dmcn
杂志官方网址：https://onlinelibrary.wiley.com/journal/14698749
出版商网址：http://www.wiley.com/WileyCDA/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Author Guidelines
Developmental Medicine & Child Neurology
Updated June 2021
All papers should be submitted online at http://mc.manuscriptcentral.com/dmcn. Please email the editorial office with any queries about the process (dmcn@editorialoffice.co.uk).
Papers published in Developmental Medicine & Child Neurology (DMCN) are freely available online from 12 months after publication. Authors who wish to make their papers freely accessible immediately upon publication may use Wiley’s pay-to-publish service, Open Access. (See 2 Copyright below).
Note to NIH Grantees
Pursuant to NIH mandate, Wiley will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate
Open access policy in Research Excellence Framework (REF) 2021
In order to be eligible for submission to the next REF, DMCN is compliant with the REF Open Access policy which states authors’ outputs must be deposited in an institutional or subject repository after an embargo period of 12 months. For further information about the policy, see https://www.ref.ac.uk/media/1228/open-access-summary–v1-0.pdf
Quick check submission table
Checklists
Submissions must be accompanied by the appropriate checklist. Read the ‘Reporting guidelines’ section below for more information.
Disclosure of interests
The DOI form must be completed and submitted to the Editorial Office with your manuscript.
Title
Should be direct and cover the main focus of the paper.
Authors
First names, middle initials, and surnames. Up to 10 authors on the title page.
Affiliations
Department, institution, city, and country. Include at least one affiliation per author.
Corresponding author
Postal and e-mail address for corresponding author.
Abbreviations
List abbreviations that are not commonly used. Avoid using abbreviations of two letters wherever possible.
Abstract
Original articles, systematic reviews, and scoping reviews should follow the structure: AIM, METHOD, RESULTS, INTERPRETATION up to 200 words.
Invited reviews, clinical practice guidelines, and case series should have unstructured abstracts up to 150 words.
Short title
Original articles only. Provide a shortened title, up to 45 characters.
What this paper adds
Max 12 words each. The bullet points should contain only new results offered by the paper.
Up to 5 points for original articles, systematic reviews, scoping reviews, and clinical practice guidelines.
Up to 2 points for other article types.
Main text
Manuscripts should be concise and clear.
Acknowledgements
List sources of funding or support and any conflict of interest.
Supporting information
Cite in the main text and list all supporting files after the main text.
References
Vancouver style is used. Original articles, invited reviews, and clinical practice guidelines should have a max of 30; systematic and scoping reviews may have more; max 15 for case series; max 5 for commentaries, editorials, and letters to the editor.
Tables/Figures
Max 4 per paper. Keep descriptions brief and explain abbreviations in table description.